Poor medication adherence, but not baseline symptoms of#psychosis or#depression, found to predict injurious#violence among patients with#schizophrenia,@YalePsych study finds.http://bit.ly/2ILYdwm #ForensicPsychiatrypic.twitter.com/vxoSK72GVP

Age, hypomanic symptoms shown to help guide clinicians to specific next-step treatment selections for#depression:http://bit.ly/2Vkh6tN pic.twitter.com/iEHfSzIPeV

The second product of ENIGMA's ADHD Working Group, led by Martine Hoogman (@HoogmanM). Subtle case-control differences in surface area of many brain regions - strongest in young children, and association with inattention also in the general population.@enigmabrains@DondersInsthttps://twitter.com/AmJPsychiatry/status/1121088409911488512 …

New#MetaAnalysis identifies cortical phenotypes associated with#ADHD that are beyond narrowly defined clinical diagnoses, suggesting that ADHD may be a continuous trait in the population.http://bit.ly/2VUQVdO @radboudumc@BFranke_labpic.twitter.com/tzB9EN4hEa

Optimizing the efficacy of#psychotherapy, cognitive training, and Internet interventions:http://bit.ly/2OsIumV #PTSD#CBTpic.twitter.com/3xkt3QVP7w

“In the case of Internet-based#CBT for#insomnia, early identification of potential treatment failures that can be addressed to alter treatment trajectory is key to making this model of care truly scalable.”http://bit.ly/2UYmaHv #editorialpic.twitter.com/ptsgWpdq8G

Our latest#CME offerings cover topics on Moyamoya disease, prolonged exposure vs. sertraline for treatment of#PTSD, and adapting treatment to prevent failure in Internet-delivered#CBT:http://bit.ly/2DxJuzd pic.twitter.com/JTCNMPcmR8

“Cognitive enhancement therapy has a growing track record of demonstrated effectiveness for improving cognitive and psychosocial outcomes in#schizophrenia spectrum disorders.”http://bit.ly/2D9rxJQ #editorialpic.twitter.com/rctt6qhmPw

It is critical for psychiatrists to be aware of disorders like#Moyamoya that present w neuropsychiatric symptoms, masquerading as mental illness. Early identification can lead to curative treatment; case by Drs. Richards, Grzenda@AGrzendaMDPHD, Nelson, & Gitlin@UCLASemelhttps://twitter.com/AmJPsychiatry/status/1115986542391066628 …

In our April Editor Spotlight#video, Deputy Editor Danny Pine reviews studies on cognitive remediation#therapy and on patient treatment preference for#PTSDhttps://youtu.be/qlqzpBasUXo 

Interaction of#stress-related genes, intimate partner#violence shown to affect physiological response to stress early in life, with consequences for emotional and cognitive development.http://bit.ly/2UHNUjw pic.twitter.com/6dxzNupT2D

#Editorial: “Perhaps we are now poised to embark on true personalized cognitive training regimens for#schizophrenia.”http://bit.ly/2IjnAWl pic.twitter.com/sP1dzGzbjA

Lori Zoellner, Ph.D., of@UWPsychology joins the AJP Audio#podcast this month to talk about her research on how patient treatment preference affects outcomes in the treatment of#PTSD.http://bit.ly/AJP_Podcast pic.twitter.com/BmiiLKch2s

These patient features may help clinicians select between commonly used next-step treatments for#depression:http://bit.ly/2Vkh6tN #antidepressantspic.twitter.com/cy9BIL0nvr

Psychiatric comorbidity in#Moyamoya disease and preliminary guidelines for treatment |http://bit.ly/2FMhfjm #CMEpic.twitter.com/gtXXh25Acu

A new study of predictors and moderators of remission for treatment-resistant major depressive disorder (MDD) found two subgroups of patients who may benefit from specific next-step treatments with aripiprazole or bupropion.http://apapsy.ch/blg-mdd-new-treatment …pic.twitter.com/XQ6F9H382d

Depression polygenic risk score derived from adults may predict major#depression and age at onset in youths as well as risk for the development of depressive symptoms over time.http://bit.ly/2uDT5SV @ThoraHalldors@Binder_Labpic.twitter.com/xDzIJ94FST

New#editorial discusses differences in the treatment literatures for#PTSD and#depression |http://bit.ly/2UgcmbF pic.twitter.com/dpSo9NrQYh

Repeat infusions of#ketamine, starting thrice weekly then transitioning to once weekly, elicit a cumulative and sustained antidepressant response in patients with treatment-resistant#depression.http://apapsy.ch/blg-ketamine-depression …#MentalHealthpic.twitter.com/4Von2XJe6v

New@TheRoyalMHC/@uOttawa study finds that repeated and maintenance#ketamine infusions can sustain reductions in symptoms of#depression:http://bit.ly/2Yx9p5C pic.twitter.com/oHzFyZB6Iw